Procter & Gamble Health's Stock Sees Decline, Underperforms Sector by -6.05%

Procter & Gamble Health, a midcap pharmaceutical company, has recently seen a decline in its stock price. On February 14, 2024, the company's stock lost -6.68%, underperforming the sector by -6.05%. This has led to a 'Hold' call by MarketsMOJO.

The stock has been on a consecutive fall for the last two days, with a -7.69% decrease in returns during this period. It also opened with a loss of -3.48% today and touched an intraday low of Rs 5135 (-6.69%). However, the stock's moving averages are still higher than the 50 day, 100 day, and 200 day averages, but lower than the 5 day and 20 day averages.

In comparison to the Sensex performance, Procter & Gamble Health's 1 day performance is -6.37%, while the Sensex has only seen a -0.97% decrease. Similarly, in the past month, the company's performance has been -1.14%, while the Sensex has seen a -2.35% decrease.

Despite these recent declines, Procter & Gamble Health remains a midcap company in the pharmaceutical industry. As a neutral and informative article, it is important to note that this is not a recommendation to buy or sell the stock. This information is based on facts and data provided by the company and MarketsMOJO.